ArticleRSC advances2025
Combined effects of transition metal nitrogen and graphene nanoribbon edge active sites on the oxygen reduction reaction catalytic performance of metal-N-carbon-based catalysts.
Article in RSC advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Escaping the Scaling Relationships in Oxygen Reduction Catalysis: Implications for PEM Fuel Cells.Advanced materials (Deerfield Beach, Fla.) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Metal-nitrogen-carbon (metal-N-C)-based catalysts with optimized local and external structures have received considerable attention owing to their improved activity and stability for the oxygen reduction reaction (ORR) in fuel cells. Abundant well-defined active sites on catalysts effectively enhance ORR performances. Herein, the Fe/Co-nitrogen-carbon-graphene nanoribbons (Fe/Co-N-C-GNRs) hybrids were obtained through the
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.